coronary artery disease
Auto Added by WPeMatico
                    
          MagicTouch Brazil Approval: A Turning Point for Cardiovascular Innovation
São Paulo (Brazil), September 17: The Brazilian health sector has just experienced a turning point with the MagicTouch Brazil Approval from ANVISA, the health surveillance national authority. Concept Medical Group, the drug-delivery technology market leader, has obtained commercial approval for its lead Sirolimus-Coated Balloon (SCB) — MagicTouch — marking the first and sole device to […]
Read More
                    
          Concept Medical Enrolls First Patient in MAGICAL-SV IDE Trial, Expands Coronary Program Globally
Tampa (Florida) [USA], August 4: Concept Medical Inc., a global pioneer in drug-delivery technologies, today announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch sirolimus-coated balloon (SCB) for the treatment of […]
Read More